A recent review has highlighted the growing need to manage facial hyperpigmentation conditions beyond melasma. Researchers explained that several pigmentation disorders often resemble melasma. However, each condition requires a different treatment approach for effective management.
The review examined the causes, diagnosis, and treatment options for multiple facial hyperpigmentation disorders. Researchers stressed that accurate diagnosis remains essential for successful treatment outcomes. Facial hyperpigmentation occurs when excess melanin darkens patches of skin. Sun exposure, inflammation, hormonal changes, and certain medications often trigger these conditions. Many disorders share similar clinical features, which complicates diagnosis.
Post-inflammatory hyperpigmentation and common triggers
Researchers identified post-inflammatory hyperpigmentation as one of the most common conditions mistaken for melasma. Acne, eczema, burns, and cosmetic procedures frequently trigger this condition. The review noted that inflammation stimulates excess melanin production, causing dark patches on the skin.
The study also discussed lichen planus pigmentosus and erythema dyschromicum perstans. These chronic disorders often affect people with darker skin tones. Both conditions produce greyish or brown facial pigmentation that resembles melasma.
Drug-induced pigmentation and treatment complications
Drug-induced hyperpigmentation also presents diagnostic challenges. Certain antibiotics, antimalarials, chemotherapy agents, and psychotropic drugs can cause facial discolouration. Researchers advised clinicians to review patient medication histories carefully.
The review highlighted exogenous ochronosis as another important condition. Long-term use of hydroquinone-containing creams can trigger this disorder. Patients develop blue-black pigmentation, especially after prolonged unsupervised treatment.
Diagnostic tools for accurate assessment
Researchers emphasised the importance of dermoscopy in diagnosis. Dermoscopy helps clinicians evaluate pigment depth and distribution patterns. This tool improves diagnostic accuracy and reduces treatment delays. Wood’s lamp examination also assists clinicians in determining pigmentation depth. Epidermal pigmentation usually responds better to topical therapies than dermal pigmentation. Accurate assessment guides treatment planning.
The review stressed the importance of individualised treatment strategies. Clinicians should identify underlying triggers before starting therapy. Treatment often combines topical agents, oral medications, sun protection, and procedural interventions.
Topical therapies and procedural options
Topical therapies remain the first-line treatment for many hyperpigmentation disorders. Common agents include hydroquinone, azelaic acid, kojic acid, cysteamine, and retinoids. These medications reduce melanin production and improve skin tone. Researchers also discussed the role of chemical peels and laser therapies. These procedures may improve resistant pigmentation cases. However, clinicians should exercise caution in patients with darker skin tones due to higher complication risks.
Photoprotection and long-term management
Strict photoprotection remains essential for all patients with facial hyperpigmentation. Researchers recommended broad-spectrum sunscreens with visible light protection. Sun exposure often worsens pigmentation and increases recurrence risk.
Psychological impact and clinical awareness
The review also addressed the psychological impact of facial pigmentation disorders. Many patients experience reduced self-esteem, social anxiety, and emotional distress. Researchers encouraged clinicians to consider mental well-being during treatment.
Experts concluded that managing facial hyperpigmentation requires a comprehensive and personalised approach. They advised clinicians to move beyond a melasma-centred perspective. Early diagnosis and targeted treatment can improve patient outcomes significantly. The review reinforces the need for greater awareness of diverse pigmentation disorders.